Obstructive sleep apnea basics ■ ABSTRACT
Obstructive sleep apnea (OSA) is a condition caused by repeated episodes of upper airway collapse and obstruction during sleep associated with arousal from sleep with or without oxygen desaturation. OSA is a highly prevalent condition, particularly in individuals with established risk factors and comorbid conditions. Screening for OSA includes a sleep history, review of symptoms, and physical examination, the results of which can identify patients that need testing for OSA. The polysomnogram or home sleep apnea test results aid in the diagnosis of OSA and its severity.
■ KEY POINTS
OSA is characterized by repeated episodes of complete or partial obstruction of the airway during sleep.
The prevalence of OSA is underestimated and underdiagnosed.
A sleep history, simple upper airway examination, and quick validated screening tool like the STOP-BANG or Epworth Sleepiness Scale aid in identifying the need for testing for OSA.
Polysomnogram is the gold standard for evaluation of OSA. Home sleep apnea tests can be used to confi rm a diagnosis of OSA in patients at high risk for moderate to severe OSA.
■ DEFINITION
Obstructive sleep apnea (OSA) occurs when there are recurrent episodes of upper airway collapse and obstruction during sleep associated with arousals with or without oxygen desaturations. The oropharynx in the back of the throat collapses during OSA events to cause arousal or oxygen desaturation or both resulting in fragmented sleep.
■ PREVALENCE
Studies reveal OSA is prevalent. A 2015 study in Switzerland reported 50% of men and 23% of women had at least moderate OSA. 1 In 2002, the Sleep Heart Health study found that 24% of men and 9% of women have at least mild OSA. 2 In the Wisconsin Sleep Study Cohort, it was reported that 10% of men and 3% of women age 30 to 49 have at least moderate OSA, while 17% of men and 9% of women age 50 to 70 have at least moderate OSA. 3 OSA is highly underrecognized and it is estimated that 82% of men and 93% of women in the United States with OSA are undiagnosed. 4 ■ SYMPTOMS There are several common sleep and daytime symptoms associated with OSA though patients vary in the number and combination of symptoms reported ( Table 1) . 5 During sleep, snoring is one of the most common symptoms. Common daytime symptoms of OSA include excessive daytime sleepiness or fatigue. Excessive daytime sleepiness is feeling very drowsy or very sleepy at times whereas fatigue is feeling tired, low on energy, and unmotivated. Feeling unrefreshed despite getting the recommended 7 to 9 hours of sleep is also a symptom.
■ RISK FACTORS
The risk of OSA is infl uenced by unmodifi able and modifi able factors. Unmodifi able risk factors include male sex, age, and race. Genetic predisposition or a family history of OSA as well as cranial facial anatomy resulting in narrow airways may impart higher VENSEL RUNDO risk of OSA. Modifi able risk factors include obesity, medications that cause muscle relaxation and narrowing of the airway (opiates, benzodiazepines, alcohol), endocrine disorders (hypothyroidism, polycystic ovarian syndrome), smoking, and nasal congestion or obstruction. 6
Sex
Men are at higher risk for OSA than women although once women reach menopause they have a risk similar to men. Postmenopausal women on hormone replacement therapy were found to have lower rates of OSA, suggesting that loss of hormones results in greater risk of OSA. 7, 8 Women also have more OSA during rapid eye movement (REM) sleep and less OSA when sleeping supine, whereas most men have OSA when sleeping supine. 9, 10 OSA is less severe in women compared with men of similar body mass index (BMI). 11 Symptoms vary in men and women: snoring and witnessed apneas are more common in men whereas insomnia and excessive daytime sleepiness are more common in women. 11 This may account for delayed diagnosis and the higher mortality in women compared with men.
Age
The risk of OSA increases with age. In a study of men 65 or older, the prevalence of moderate OSA was 23% in men younger than 72 and 30% in men older than 80. 12 By comparison, the prevalence of moderate OSA in men 30 to 40 years was 10%. 3 Increased risk of OSA with age may be due to age-related reduction in slow wave sleep (ie, deep sleep), which is protective against sleep-disordered breathing and airway collapse. 13 Older adults are also less symptomatic, reporting less daytime sleepiness and fatigue. 14 
Race
The Sleep Heart Health Study found a slightly increased risk of moderate to severe OSA in blacks (20%) and American Indians (23%) compared with whites (17%). 2 Another study showed the prevalence of OSA was 30% in whites, 32% in blacks, 38% in Hispanics, and 39% in Chinese individuals. 15 A higher prevalence of OSA in young blacks (≤ 25 years) compared with whites was reported, 16 although another study found no differences based on race in older patients. 17 These differences among racial groups may be due to variations in craniofacial anatomy.
Obesity
There is a correlation between increased risk of OSA and obesity (BMI > 30 kg/m 2 ) and its correlates of greater waist-to-hip ratio and neck circumference. 2 A 10% increase in body weight results in a sixfold increase in moderate to severe OSA and increases the apnea-hypopnea index (AHI; number of breath pauses or respiratory events per hour) by 32% whereas a 10% decrease in weight decreases the AHI by 26%. 18 ■ COMORBIDITIES OSA is associated with a number of comorbid conditions including stroke, myocardial infarction, hypertension, hyperlipidemia, glucose intolerance, diabetes, arrhythmias including atrial fi brillation, pulmonary hypertension, congestive heart failure, and depression. Patients with moderate or severe OSA are at higher risk of these comorbid conditions. 19 Patients with cardiovascular disease have a very high prevalence of OSA: hypertension (83% mild to 30% moderate to severe OSA), heart failure (55% to 12%), arrhythmias (50% to 20%), stroke (75% to 57%), and coronary heart disease (65% to 38%). 20 Increased awareness and early diagnosis of OSA is critical to reducing cardiovascular disease burden.
■ SCREENING Screening patients for OSA starts with a good sleep history to identify symptoms, risk factors, and comorbid conditions, as well as a physical examination for OSA-related features ( Table 2 ). The Epworth Sleepiness Scale and STOP-BANG questionnaire are brief, effective screening tools that can inform the need for further testing. Drowsy driving is a special concern in patients with untreated OSA and sleep deprivation. Many patients have drowsy driving episodes or diffi culty staying awake during long-distance driving. Caffeine use is also important information as excessive caffeine may be used to combat sleepiness during the day.
The Epworth Sleepiness Scale is a clinical screening tool that presents 8 situations for patients to consider and indicate their level of sleepiness and likelihood of falling asleep (never = 0; slight = 1; moderate = 2, high = 3). 21, 22 A total score ≥ 10 is considered abnormal in that the patient is excessively sleepy compared with most people.
Risk factors and comorbid conditions. OSA risk factors and comorbidities, including a BMI obesity assessment, should be reviewed with patients. Nasal congestion or mouth breathing especially at night could be due to airway obstruction increasing the risk of OSA. Family history of OSA, tobacco, alcohol use, other medical conditions, and medications should also be discussed.
Physical examination
Certain fi ndings on physical examination could suggest the presence of OSA:
• Neck circumference greater than 17 inches for men or greater than 16 inches for women • BMI greater than 30 • Friedman class tongue position class 3 or greater (Figure 1 ) • Mouth features (present/enlarged tonsils, macroglossia, jaw misalignment) • Nasal abnormalities (turbinate hypertrophy, deviated septum). 5 Patients with Friedman palate positions class 3 and 4 have a higher risk of OSA due to airway crowding during sleep when the airway naturally collapses a little and is even more restricted.
Narrow airways or oropharyngeal crowding can also be due to a swollen, enlarged, or elongated uvula; present or enlarged tonsils; or lateral wall narrowing. Alone or in combination, these features can contribute to airway obstruction.
Other signs in the mouth suggestive of obstruction are macroglossia (enlarged tongue) and tongue ridging. Tongue ridging or scalloping impressions typically occur during sleep and are caused by the tongue moving forward to open the airway and pressing against the teeth. 
Normal sleep

Respiratory event-related arousal
Reduction in airfl ow in the nasal transducer and airfl ow leads (A) and slight oxygen desaturation (B) and arousal from sleep in the electroencephalogram leads (C).
Obstructive apnea
Airfl ow in the nasal transducer and the airfl ow leads (A) show no airfl ow but there is persistent effort in the chest and abdomen leads (B). Oxygen desaturation (C) and arousal in the electroencephalogram leads (D) also occurs in association with this respiratory event. 
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Retrognathia (lower jaw offset behind upper jaw) can narrow the airway and increase the risk of OSA as can a high arch palate, overbite (upper teeth forward), or overjet (upper teeth over the top of lower teeth).
A nasal examination for nasal valve collapse (ie, nostril collapses with inhalation), deviated septum, and inferior turbinate hypertrophy impart an increased risk of OSA.
Screening tools
In addition to the Epworth Sleepiness Scale, the STOP-BANG questionnaire can help determine if a patient should be tested further for OSA. The STOP-BANG questionnaire consists of 8 yes-no questions where more than 2 yes responses indicate the patient is at higher risk for moderate to severe OSA (93% sensitivity): Snore, Tired, Observed stopped breathing, high blood Pressure, BMI > 35 kg/m 2 , Age > 50, Neck > 15.75 inches, Gender = male). 23 
SLEEP STUDIES
Polysomnography (PSG) is the gold standard of evaluation for OSA. The more recently availabile home sleep apnea test (HSAT) is convenient for select patients as a confi rmatory test but results may underestimate the severity of sleep-related breathing disorders.
Polysomnography PSG is a monitored, 8-hour sleep study conducted in a laboratory with an established scoring criteria for OSA-related respiratory events. 24 The test can be tailored to a patient's clinical history to determine the need for supplemental oxygen and positive airway pressure titration, detect elevated carbon dioxide (hypercapnia or hypoventilation) due to shallow breathing, and monitor for seizures or parasomnias. The PSG also records REM and nonREM sleep for REMrelated sleep disorders, body position (supine and off supine), and variability in muscle tone that corresponds to the different stages of sleep (Figure 2 , Table 3 ).
Hypnogram. A hypnogram is a type of polysomnography that illustrates the different stages of sleep over time: wake, stage 1, stage 2, and stage 3, and REM sleep (Figure 3) . In a typical night's sleep of 7 to 9 hours, patients cycle through the sleep stages 4 to 5 times. A hypnogram can also include waveforms for other parameters such as body position, respiratory events (apnea and hypopneas), microarousals, continuous positive airway pressure therapy, and oxygen saturation.
Home sleep apnea test
HSATs record 4 to 7 parameters including airfl ow (thermal and nasal pressure), effort (inductive plethysmography), and oximetry. No electroencephalogram is used, so sleep is not recorded; it is assumed the patient is sleeping for the duration of the test. As such, respiratory events are based on oxygen desaturations and reduced airfl ow and pressure as well as chest and abdomen effort. The raw data are edited and manually scored and reviewed by a sleep specialist. 25 Although the HSAT is convenient for many HSAT is intended to confi rm OSA in patients with a high likelihood of OSA based on their sleep history. 26 It is ideally employed for adult patients with no major medical problems or other sleep problems who are at high risk for moderate to severe OSA based on the STOP-BANG questionnaire or those with daytime sleepiness and 2 of the 3 symptoms of snoring, witnessed apnea, or hypertension. 27 
Respiratory events captured on a PSG or HSAT
The OSA diagnostic criteria are based on the occurrence of obstructive respiratory events recorded during sleep such as apneas, hypopneas, and respiratory event-related arousals.
Apneas. An apnea is a respiratory event resulting in a complete lack of airfl ow as measured by a greater than 90% reduction in thermal sensor for 10 or more seconds. Apneas can be obstructive, central, or mixed (Figure 4) . Obstructive apneas occur when the airway is closed and respiratory effort is present in the chest and abdomen (Figure 2) . In central apnea, there is no airfl ow and no respiratory effort, meaning the brain is not directing the body to breathe. Mixed apneas cause a lack of airfl ow with and without respiratory effort.
Hypopneas. A hypopnea is a respiratory event resulting in reduced airfl ow. The America Association of Sleep Medicine's preferred defi nition is a reduction in nasal pressure of at least 30% for 10 seconds or longer with 3% or greater oxygen desaturation or an electroencephalogram arousal. Another acceptable defi nition is at least 30% reduction in thoracoabdominal movement or airfl ow with 4% or greater oxygen desaturation, which is used by the Centers for Medicare and Medicaid Services and other insurers. 29, 30 Hypopnea requires greater oxygen desaturation and is not dependent on arousals, which can sometimes make it more challenging to identify OSA (Figure 2) .
Respiratory event-related arousals. Respiratory event-related arousals are respiratory events not meeting apnea or hypopnea criteria. They are measured 
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Mixed (no airfl ow with and without respiratory effort)
Central
(no airfl ow and no respiratory effort)
Obstructive (no airfl ow with respiratory effort)
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as a sequence of breaths of 10 or more seconds with increasing respiratory effort or fl attening of the nasal pressure waveform leading to arousal (Figure 2) . 29 Respiratory event-related arousals are disruptive to sleep and have many of the same consequences as apneas and hypopneas.
Severity
A diagnosis of OSA should include a measure of severity (mild, moderate, or severe) as the severity may determine if a patient with OSA is treated or not. Severity is determined by AHI, respiratory disturbance index, or respiratory event index ( Table  5 ). 29 For any of the 3 indexes, a value 5 to 14.9 is considered mild, 15 to 29.9 is considered moderate, and 30 or greater is considered severe.
■ SUMMARY OSA results from airway collapse and obstruction during sleep, often causing arousal from sleep with or without oxygen desaturation. The prevalence of OSA is underestimated and it is underdiagnosed despite known risk factors and comorbid conditions. Screening for OSA with a sleep history, simple upper airway examination, and quick validated screening tool like the STOP-BANG or Epworth Sleepiness Scale aid in identifying the need for testing for OSA.
A laboratory sleep study with a PSG can confi rm the diagnosis and severity of OSA. HSATs are available to confi rm the diagnosis of OSA in patients at high risk for moderate to severe OSA. 
